193
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluations

Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older

, MD, , MD & , PhD
Pages 1559-1567 | Published online: 19 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alexei Gonzalez-Estrada, Keerthi Reddy, Ves Dimov & Frank Eidelman. (2017) Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opinion on Pharmacotherapy 18:11, pages 1137-1143.
Read now
Andrew S Nickels, Vesselin Dimov & Raoul Wolf. (2011) Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis. Expert Opinion on Drug Metabolism & Toxicology 7:12, pages 1593-1599.
Read now

Articles from other publishers (4)

Rohit Shetty, VaitheeswaranGanesan Lalgudi, Pooja Khamar, Krati Gupta, Swaminathan Sethu, Archana Nair, SantoshG Honavar, Arkasubhra Ghosh & Sharon D'Souza. (2020) Potential ocular and systemic COVID-19 prophylaxis approaches for healthcare professionals. Indian Journal of Ophthalmology 68:7, pages 1349.
Crossref
Soo-Wan Choi, Ju-Hee Ryu, Ji-Sun Park, Myung-Jae Lee, Sung-Vin Yim & Kyung-Tae Lee. (2015) Development and validation for the determination of olopatadine in human plasma by liquid chromatography–tandem mass spectrometry: application to a bioequivalence study of Ilhwa Allotadine tablet (olopatadine HCl 5 mg). Journal of Pharmaceutical Investigation 45:3, pages 285-292.
Crossref
Thuy-Anh N. Melvin & Alpen A. Patel. (2011) Pharmacotherapy for Allergic Rhinitis. Otolaryngologic Clinics of North America 44:3, pages 727-739.
Crossref
Tadafumi Tamura. (2011) Investigation of the antiallergic activity of olopatadine on rhinitis induced by intranasal instillation of antigen in sensitized rats using thermography. Asia Pacific Allergy 1:3, pages 138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.